Synovial Sarcoma Gene Mutation Panel, NGS
Synovial sarcoma (SS) is the malignant neoplasm arises in the synovial membranes of the joints and the synovial cells of the tendons and bursa. This tumor most commonly occurs in the deep soft tissue of the extremities, especially around the knee, however, it may also involve the abdominal wall and other trunk muscles. Histological subtypes of SS include biphasic tumors containing epithelia-like/spindle cells, monophasic tumors containing only spindle cells, and poorly differentiated tumors. These sarcomas occur most commonly in the second and fourth decades of life and are more common in males. SS makes up about 5–10 % of soft tissue sarcomas affecting young adults.
The majority of synovial sarcomas are characterized by a chromosomal translocation involving the SS18 gene on chromosome 18q11 and one of three homologous genes on the X-chromosome (SSX1, SSX2, SSX4). The SSX1-SS18 fusion is associated with biphasic tumors while SSX2-SS18 is associated with monophasic tumors.
Clinically there is a high rate of metastatic disease at initial diagnosis with spread to either the lungs, lymph nodes, or bone. Local recurrence is also common after resection. Treatment of SS includes surgical resection with or without radiotherapy for primary disease. Ifosfamide with or without doxorubicin has been used as chemotherapeutic agents for systemic treatment. Synovial sarcoma has a 5-year survival rate ranging from 36-76 % and a 20-63 % 10 year survival.
- Diagnostic confirmation of synovial sarcoma
- For the detection of chromosomal translocation associated SS18-SSX-fusion gene
- For the clinical management and treatment of synovial sarcoma
Positive:
- SS18-SSX-fusion gene detected
Negative:
- SS18-SSX-fusion gene not detected.
Negative for SS18-SSX-fusion gene
Formalin-fixed, paraffin-embedded (FFPE) tissue.
Stability
- Ambient: Indefinitely
- Refrigerated: Indefinitely
- Frozen: Unacceptable
- Oncotarget. 2018;9: 36878-36888. [PMID: 30627328]
- J Mol Diagn. 2018 Sep;20(5):653-663. [PMID: 30139549]
- Oncotarget. 2015;6: 34680-90. [PMID: 26415226]
- Expert Rev Anticancer Ther. 2014;14: 791-806. [PMID: 24661286]
- Cancer. 2009;115: 3537-47. [PMID: 19514087]
- Orthopedics. 2007;30: 1020-5. [PMID: 18198773]